Intrexon | XON - 当期純利益





当期純利益 変化する 日付
Agenus USD 39.17M 49.8M 2026-03
Alaunos Therapeutics USD -952K 54K 2026-06
Amgen USD 3.86B 1.49B 2026-09
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD -194.28M 61.55M 2026-06
AstraZeneca USD 3.12B 610M 2026-09
Bristol-Myers Squibb USD 2.16B 1.16B 2026-09
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 1.54B 1.11B 2026-09
Heron Therapeutics USD -2.95M 14.54M 2025-12
Incyte USD -784.8M 1.37B 2026-09
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
Ligand Pharmaceuticals USD -28.48M 76.99M 2026-09
MacroGenics USD 19.52M 56.29M 2026-06
MannKind USD -19.03M 2.41M 2026-06
Merck USD 5.07B 6.4B 2026-09
Novartis USD 1.2B 2.06B 2026-09
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Roche Holding CHF 6.87B 1.4B 2026-06
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Thermo Fisher Scientific USD 1.72B 15M 2026-09
Veracyte USD 31.5M 6.01M 2026-09
Xencor USD -21.73M 107.19M 2026-06